D
Relmada Therapeutics, Inc. RLMD
$0.627 $0.0172.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 21.85% 19.71% 19.04% 22.48% 32.74%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -39.75% -37.66% -32.34% -19.57% -17.00%
Change in Net Operating Assets -345.82% -251.37% -151.42% 116.10% 122.15%
Cash from Operations -3.62% -17.84% -0.19% 31.16% 47.93%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 38.83% 177.27% 2.20% 16.81% -48.11%
Cash from Investing 38.83% 177.27% 2.20% 16.81% -48.11%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -100.00% -100.00% -- 579.61% -62.36%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -171.34% -112.23% -191.47% -157.04% -138.16%
Cash from Financing -372.00% -312.74% 58.98% -91.80% -87.42%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 94.08% 99.33% 82.01% 85.44% 45.67%